Ecuador · Spanish · ARCSA
ARCSA translation, aligned to Ecuadorian regulatory practice.
What Ecuador's ARCSA expects from Spanish clinical trial and registration documentation — and how an Amavita pilot delivers a package that clears review without avoidable observaciones.
What this covers
ARCSA in three moving parts.
What must be in Ecuadorian Spanish
Protocol, informed consent, investigator's brochure, safety narratives, and labeling — with Ecuadorian medical terminology and patient-facing language that matches local usage.
Certification and legalization
Legal instruments require an official translator recognized in Ecuador and, for foreign public documents, apostille under the Hague Convention or consular legalization.
Where submissions stall
Inconsistent INN usage, dosing rendered literally from English, and missing appendix translations are recurring causes of ARCSA observaciones.
What must be in Ecuadorian Spanish
Protocol, informed consent, investigator's brochure, safety narratives, and labeling — with Ecuadorian medical terminology and patient-facing language that matches local usage.
Certification and legalization
Legal instruments require an official translator recognized in Ecuador and, for foreign public documents, apostille under the Hague Convention or consular legalization.
Where submissions stall
Inconsistent INN usage, dosing rendered literally from English, and missing appendix translations are recurring causes of ARCSA observaciones.
Ready to scope your Ecuador pilot?
Start the pilot form and get a timeline in 2 business days.
Document checklist
ARCSA pre-submission checklist.
A pre-submission checklist covering the required forms, translations, certification, and submission steps for ARCSA clinical trial and marketing authorization dossiers. Use it to scope a pilot or QC a package before filing.
Required forms and administrative documents
- Solicitud de autorización de estudio clínico (ARCSA application form), signed by the local sponsor representative.
- Power of attorney (poder) naming the local regulatory representative — apostilled if issued abroad.
- Sponsor authorization letter and CV of the coordinating investigator.
- CEISH approval letter from an accredited ethics committee.
- Insurance certificate covering trial subjects in Ecuador.
- GMP certificate and Certificate of Pharmaceutical Product (CPP) for the investigational product.
- Proof of ARCSA fee payment (comprobante de pago).
Translations required in Ecuadorian Spanish
- Clinical trial protocol and any amendments.
- Investigator's Brochure (IB) with all appendices and safety updates.
- Informed Consent Form (ICF) and any assent forms, adapted to Ecuadorian reading level.
- Patient-facing materials: diaries, questionnaires, recruitment ads, visit cards.
- Safety narratives, SAE reports, and DSUR summaries.
- Product labeling, Instructions for Use (IFU), and packaging inserts.
Certification and legalization
- Legal instruments translated by an official translator recognized in Ecuador.
- Foreign public documents apostilled under the Hague Convention; consular legalization only when the origin country is not a Hague party.
- Technical documents reviewed by clinicians familiar with Ecuadorian regulatory usage.
- Translator certification statement attached to each translated legal document.
Submission workflow
- Confirm the local sponsor and regulatory representative are registered with ARCSA.
- Obtain CEISH approval before submitting — ARCSA will not open review without it.
- Compile the dossier in the ARCSA-required order with a Spanish table of contents.
- Submit through the ARCSA electronic portal (VUE) with paginated PDFs and matching filenames.
- Track observaciones and respond within the ARCSA-defined window; keep a versioned translation log.
- Notify ARCSA of protocol amendments, SUSARs, and annual safety reports in Spanish on the required timelines.
Frequently asked
ARCSA translation, quick answers.
What language does ARCSA require for clinical trial submissions in Ecuador?
ARCSA reviews clinical trial dossiers in Spanish. Protocols, informed consent forms, investigator's brochures, safety narratives, and product labeling must be translated into Ecuadorian Spanish, with source-language documents accepted only when paired with a compliant translation.
Who certifies translations for ARCSA submissions?
Legal instruments and foreign public documents require an official translator recognized in Ecuador and, where applicable, apostille or consular legalization. Technical documents should be prepared by qualified medical translators reviewed by clinicians familiar with Ecuadorian regulatory usage.
Does ARCSA accept apostilled documents from the United States or Europe?
Yes. Ecuador is a party to the Hague Apostille Convention, so foreign public documents (powers of attorney, GMP certificates, CPPs, notarized authorizations) are accepted with an apostille from the issuing country's competent authority. The apostilled document and its Spanish translation are submitted together; consular legalization is only needed when the origin country is not a Hague party.
Do informed consent forms need review by an Ecuadorian ethics committee (CEISH)?
Yes. Clinical trial ICFs are reviewed by a Comité de Ética de Investigación en Seres Humanos (CEISH) accredited by the Ministerio de Salud Pública before ARCSA authorization. Translations should reach the CEISH at an accessible reading level in Ecuadorian Spanish, with local site, sponsor, and contact details already localized — not left as English placeholders.
How should drug names and dosing be handled in ARCSA translations?
Use the INN (Denominación Común Internacional) consistently across protocol, ICF, IB, and labeling, with the brand name in parentheses on first mention where relevant. Dosing, units, and concentrations follow SI conventions and Ecuadorian prescribing usage — never a literal carry-over of US units or English phrasing — and abbreviations are spelled out on first use to avoid observaciones.
How long does an ARCSA clinical trial translation pilot take with Amavita?
A single-protocol pilot typically delivers an MD-reviewed Ecuadorian Spanish package (protocol, ICF, and one supporting document) within two to three weeks of kickoff, followed by a pre-submission QC pass covering terminology, ICF readability, and legalization workflow. Timelines scale with dossier size and are confirmed in the scoped proposal returned within two business days.
How does the Amavita pilot cover ARCSA submissions?
A pilot scopes one Ecuadorian protocol or dossier, delivers an MD-reviewed Spanish package aligned to ARCSA expectations, and includes a pre-submission QC checklist covering terminology, ICF readability, and legalization workflow.
Next step
Scope a Ecuador pilot this quarter.
Share your Ecuador protocol or registration dossier. Our team will reach out within 2 business days with a scoped pilot proposal and timeline.